Question 1

Does BlackRock own INKT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, BlackRock holds 13,382 shares of INKT (Mink Therapeutics), worth $156,435.

Question 2

How many shares of INKT does BlackRock own?

Accepted Answer

As of its Q2 2026 13F, BlackRock holds 13,382 shares of INKT (Mink Therapeutics).

Question 3

What is BlackRock's INKT position worth?

Accepted Answer

As of its Q2 2026 13F, BlackRock's INKT position is worth $156,435.

Question 4

Is BlackRock buying or selling INKT?

Accepted Answer

In Q2 2026, BlackRock increased its INKT position by 7,179 shares (+115.7%).

Question 5

When did BlackRock first buy INKT?

Accepted Answer

BlackRock first reported INKT in its Q1 2025 13F and has listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	13,382	+115.7%	$156,435	0.0%	$11.69	25
2026-Q1	Unchanged	6,203	0.0%	$65,317	0.0%	$10.53	0
2025-Q4	Decreased	6,203	-1.5%	$69,164	0.0%	$11.15	0
2025-Q3	Decreased	6,298	-15.1%	$88,172	0.0%	$14.00	0
2025-Q2	Decreased	7,421	-15.5%	$54,823	0.0%	$7.39	0
2025-Q1	New	8,778	-	$75,842	0.0%	$8.64	33

INKT6 quarters

INKT
6 quarters